D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 54 Citations 7,853 205 World Ranking 1717 National Ranking 49

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Virus

His primary scientific interests are in Internal medicine, Immunology, Gastroenterology, Hepatitis C and Ribavirin. Pablo Barreiro mostly deals with Liver disease in his studies of Internal medicine. His work is connected to Hepatitis C virus, Sida, Viral disease, Viral load and Lentivirus, as a part of Immunology.

The concepts of his Gastroenterology study are interwoven with issues in Atazanavir and Immunopathology. His research integrates issues of Coinfection and Hepatitis B in his study of Hepatitis C. His study on Ribavirin is covered under Virology.

His most cited work include:

  • Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir. (237 citations)
  • Pegylated Ifn-α2b plus ribavirin as therapy for chronic hepatitis C in Hiv-infected patients (187 citations)
  • Antiretroviral drugs and liver injury (186 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Internal medicine, Virology, Immunology, Hepatitis C and Gastroenterology. His Internal medicine study integrates concerns from other disciplines, such as Didanosine, Sida, Ribavirin and Viral load. The study incorporates disciplines such as Hiv infected patients and Drug resistance in addition to Virology.

As a part of the same scientific study, he usually deals with the Immunology, concentrating on Acquired immunodeficiency syndrome and frequently concerns with Pharmacotherapy. His Hepatitis C study incorporates themes from Viral hepatitis, Hepatitis, Sofosbuvir, Boceprevir and Coinfection. The Gastroenterology study combines topics in areas such as Fibrosis and Atazanavir.

He most often published in these fields:

  • Internal medicine (43.29%)
  • Virology (34.76%)
  • Immunology (32.93%)

What were the highlights of his more recent work (between 2015-2021)?

  • Virology (34.76%)
  • Hepatitis C (28.66%)
  • Coronavirus disease 2019 (3.35%)

In recent papers he was focusing on the following fields of study:

Virology, Hepatitis C, Coronavirus disease 2019, Internal medicine and Severe acute respiratory syndrome coronavirus 2 are his primary areas of study. His Hepatitis C study necessitates a more in-depth grasp of Immunology. His study of Coinfection is a part of Immunology.

He works mostly in the field of Coronavirus disease 2019, limiting it down to topics relating to 2019-20 coronavirus outbreak and, in certain cases, Pneumonia, Polymerase chain reaction, Antigen testing and Hiv infected patients, as a part of the same area of interest. His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology, Dolutegravir, Malaria and Diabetes mellitus. His study in Severe acute respiratory syndrome coronavirus 2 is interdisciplinary in nature, drawing from both Seroprevalence, High seroprevalence, Coronavirus and Vaccination.

Between 2015 and 2021, his most popular works were:

  • Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV‐positive patients (47 citations)
  • Prevention and management of treatment failure to new oral hepatitis C drugs (34 citations)
  • Treatment and prevention of HIV infection with long-acting antiretrovirals (26 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Virus

Pablo Barreiro focuses on Hepatitis C, Internal medicine, Immunology, Coinfection and Sofosbuvir. Pablo Barreiro has researched Hepatitis C in several fields, including Entecavir and Drug discovery. Pablo Barreiro interconnects Diabetes mellitus and Dolutegravir in the investigation of issues within Internal medicine.

His study looks at the relationship between Coinfection and topics such as Acquired immunodeficiency syndrome, which overlap with Clinical research, Family medicine, Hepatitis, Tuberculosis and Viremia. His Sofosbuvir research integrates issues from Daclatasvir, Pharmacokinetics, Pharmacology, Cirrhosis and Voxilaprevir. Hepatitis B is a subfield of Virology that Pablo Barreiro explores.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir.

Pablo Labarga;Pablo Barreiro;Luz Martin-Carbonero;Sonia Rodriguez-Novoa.
AIDS (2009)

297 Citations

Pegylated Ifn-α2b plus ribavirin as therapy for chronic hepatitis C in Hiv-infected patients

Mayte Pérez-Olmeda;Marina Núñez;Miriam Romero;Juan González.
AIDS (2003)

272 Citations

Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial.

Marina Núñez;Celia Miralles;Miguel Angel Berdún;Elena Losada.
AIDS Research and Human Retroviruses (2007)

266 Citations

Viral hepatitis and HIV co-infection

Vincent Soriano;Eugenia Vispo;Pablo Labarga;Jose Medrano.
Antiviral Research (2010)

258 Citations

Antiretroviral drugs and liver injury

Vincent Soriano;Massimo Puoti;Pilar Garcia-Gascó;Juergen K Rockstroh.
AIDS (2008)

254 Citations

Influence of 516G>T polymorphisms at the gene encoding the CYP450-2B6 isoenzyme on efavirenz plasma concentrations in HIV-infected subjects.

Sonia Rodriguez-Novoa;Pablo Barreiro;Ana Rendón;Inmaculada Jiménez-Nacher.
Clinical Infectious Diseases (2005)

243 Citations

Risks and benefits of replacing protease inhibitors by nevirapine in HIV-infected subjects under long-term successful triple combination therapy.

P. Barreiro;V. Soriano;F. Blanco;C. Casimiro.
AIDS (2000)

222 Citations

Hepatotoxicity of Antiretroviral Drugs Is Reduced after Successful Treatment of Chronic Hepatitis C in HIV-Infected Patients

Pablo Labarga;Vicente Soriano;María Eugenia Vispo;Javier Pinilla.
The Journal of Infectious Diseases (2007)

214 Citations

Genetic factors influencing atazanavir plasma concentrations and the risk of severe hyperbilirubinemia.

Sonia Rodríguez-Nóvoa;Luz Martín-Carbonero;Pablo Barreiro;Gema González-Pardo.
AIDS (2007)

203 Citations

Severe liver disease associated with prolonged exposure to antiretroviral drugs.

Ivana Maida;Marina Núñez;Maria Jose Ríos;Luz Martín-Carbonero.
Journal of Acquired Immune Deficiency Syndromes (2006)

201 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Pablo Barreiro

Vincent Soriano

Vincent Soriano

Hospital Universitario La Paz

Publications: 139

Juan A. Pineda

Juan A. Pineda

Spanish National Research Council

Publications: 80

Carmen de Mendoza

Carmen de Mendoza

Instituto de Salud Carlos III

Publications: 59

Antonio Rivero

Antonio Rivero

Instituto Maimónides de Investigación Biomédica de Córdoba

Publications: 58

Jürgen K. Rockstroh

Jürgen K. Rockstroh

University Hospital Bonn

Publications: 55

Kenneth E. Sherman

Kenneth E. Sherman

University of Cincinnati Medical Center

Publications: 36

Marina Núñez

Marina Núñez

Wake Forest University

Publications: 36

Mark S. Sulkowski

Mark S. Sulkowski

Johns Hopkins University School of Medicine

Publications: 35

Marina B. Klein

Marina B. Klein

McGill University Health Centre

Publications: 35

JK Rockstroh

JK Rockstroh

University Hospital Bonn

Publications: 34

Douglas T. Dieterich

Douglas T. Dieterich

Icahn School of Medicine at Mount Sinai

Publications: 34

Stanislas Pol

Stanislas Pol

Université Paris Cité

Publications: 33

Sharon R. Lewin

Sharon R. Lewin

University of Melbourne

Publications: 33

Jens D. Lundgren

Jens D. Lundgren

Rigshospitalet

Publications: 33

David Back

David Back

University of Liverpool

Publications: 32

Saye Khoo

Saye Khoo

University of Liverpool

Publications: 31

Something went wrong. Please try again later.